<DOC>
	<DOCNO>NCT00656695</DOCNO>
	<brief_summary>Cyclosporine key drug organ transplantation . In Iran investigator 2500 new renal transplantation year government pay huge amount money subside import cyclosporine form Neoral . Recently Iranian drug company introduce drug name Iminoral approve different authority Iran abroad , ( include Ministry Health Iran also European Directorate Quality Medicines Certification Unit FDA ( Department Health Human Services , Center Drug Evaluation Research ) ) . The investigator study first clinical trial compare effect Iminoral versus Neoral prevent acute rejection renal transplantation also compare side effect two drug .</brief_summary>
	<brief_title>Comparisone Iminoral Versus Neoral Prevention Acute Rejection Renal Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>1. renal transplantation candidate 2. write consent 3. take participate clinical trial last 3 month 1. primary FSGS 2. hyperoxaluria 3. age 18 4. multi organ transplantation 5. malignancy 5 year 6 . PRA &gt; 25 % 7. use Tacrolimus 8. hyper acute rejection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Iminoral</keyword>
	<keyword>Neoral</keyword>
	<keyword>Acute renal transplant rejection</keyword>
</DOC>